Study of immune signals in newborns with early inflammation or infection
Part of Digestive system clinical trials.
This study looks at how immune-related “NETs” might protect or possibly harm newborn babies during early inflammation or infection. It may help doctors understand which immune responses are helpful versus risky in the NICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You/your baby must be in the NICU (newborn intensive care unit).
- Baby must be very small or very premature: born at 30 weeks or less, or weigh 1500 grams or less.
- If baby was born at term, delivery must happen at the University of Utah Maternity Care Center without complications.
- The umbilical cord blood must be collected within the first hour after birth.
- A parent or guardian must sign informed consent before any study procedures.
- Baby must not have major birth defects (major congenital anomalies).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the gut bacteria of premature babies to see if changes can predict a serious bowel condition (ulcero-necrotizing enterocolitis). It aims to use artificial intelligence to help doctors catch it early.
This study tests whether giving premature babies a daily probiotic (a mix of healthy bacteria) can help prevent a serious gut condition called necrotizing enterocolitis. If it works, it could keep your baby safer and healthier.
This study tests a monitoring tool to help doctors spot a serious gut problem in premature babies born before 32 weeks. If the tool works, it could lead to earlier treatment and better outcomes.
This study looks at how the immune system develops in the intestines of newborns, including those born early or with a blocked intestine (atresia). It may help doctors understand inflammation and improve care for sick babies.
This study looks at premature babies and babies with very low birth weight to better understand a serious bowel condition called necrotizing enterocolitis. It aims to find ways to identify or manage this condition in these high-risk infants.
This study looks at whether newborns with a serious gut condition called necrotizing enterocolitis (NEC) have different allergy triggers compared to healthy newborns. It may help doctors understand if allergies play a role in NEC and could guide future treatments.
Hear when a new Necrotizing Enterocolitis (NEC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.